An atlas of genetic influences on human blood metabolites

Shin et al., Nature Genetics, 2014 [ Article | SI Text ]

Locus 82: CYP2C8 (10q23.33)

Meta-analysis summary statistics for associations meeting genome-wide significance
Lead SNPBiochemicalsEA/OANtotalEAFEffect (SE)PmetaDetails
rs1934955 X-02249 A/G 7369 0.71 -0.030 (0.004) 3.33·10-16 show
rs2071426 X-11469 T/C 7330 0.71 0.052 (0.007) 3.97·10-14 show
rs2071426 X-02269 T/C 7256 0.71 0.055 (0.007) 6.87·10-14 show

EA = effect allele; OA = other allele; EAF = frequency of effect allele;

Summary of biological annotations
SNPrs1934955
Chromosomal locationChr10: 96,778,551 (10q23.33)
Gene (distance)CYP2C8 (-7,967)
Predicted causal geneunknown
Gene/protein classificationmetabolic enzyme
Metabolite (Pathway)X-02249 (Unknown)
Biochemical locus-metabolite relationshipX-02249 is an unknown metabolite
eQTL associations-

 

Medical information
Complex trait associations-
Known metabolite associations-
Inborn error of metabolism-

Pharmacological information
ChEMBL IDCHEMBL3721
Drug information Substrates: Amodiaquine, Cerivastatin, paclitaxel, rosiglitazone, repaglinide; Inhibitors: gemfibrozil, montelukast, piolitazone, quercetin, rosiglitazone, rosuvastatin, trimethorprim

Locus information for top associated metabolite

HapMap2 imputation

Imputation HapMap

1KGP imputation

Imputation 1KGP

 

Network view
Association map